139 related articles for article (PubMed ID: 16163256)
21. The role of FLT3 in haematopoietic malignancies.
Stirewalt DL; Radich JP
Nat Rev Cancer; 2003 Sep; 3(9):650-65. PubMed ID: 12951584
[TBL] [Abstract][Full Text] [Related]
22. Finding the next Gleevec: FLT3 targeted kinase inhibitor therapy for acute myeloid leukemia.
Sawyers CL
Cancer Cell; 2002 Jun; 1(5):413-5. PubMed ID: 12124170
[TBL] [Abstract][Full Text] [Related]
23. FLT3: ITDoes matter in leukemia.
Levis M; Small D
Leukemia; 2003 Sep; 17(9):1738-52. PubMed ID: 12970773
[TBL] [Abstract][Full Text] [Related]
24. FLT3-ITD-TKD dual mutants associated with AML confer resistance to FLT3 PTK inhibitors and cytotoxic agents by overexpression of Bcl-x(L).
Bagrintseva K; Geisenhof S; Kern R; Eichenlaub S; Reindl C; Ellwart JW; Hiddemann W; Spiekermann K
Blood; 2005 May; 105(9):3679-85. PubMed ID: 15626738
[TBL] [Abstract][Full Text] [Related]
25. [Pathophysiology and treatment of acute myeloid leukemia].
Naoe J
Rinsho Ketsueki; 2003 Apr; 44(4):219-26. PubMed ID: 12784654
[No Abstract] [Full Text] [Related]
26. Single-agent CEP-701, a novel FLT3 inhibitor, shows biologic and clinical activity in patients with relapsed or refractory acute myeloid leukemia.
Smith BD; Levis M; Beran M; Giles F; Kantarjian H; Berg K; Murphy KM; Dauses T; Allebach J; Small D
Blood; 2004 May; 103(10):3669-76. PubMed ID: 14726387
[TBL] [Abstract][Full Text] [Related]
27. Novel mutations in the FLT3 gene in adult patients with refractory acute myeloid leukemia.
Choi Y; Kim HJ; Park BH; Min WS; Kim CC
Leukemia; 2005 Jan; 19(1):141-3. PubMed ID: 15510198
[No Abstract] [Full Text] [Related]
28. Flt3 in acute myelogenous leukemia: biology, prognosis, and therapeutic implications.
Voutsadakis IA
Med Oncol; 2003; 20(4):311-24. PubMed ID: 14716027
[TBL] [Abstract][Full Text] [Related]
29. Acute myeloid leukemia with t(6;9)(p23;q34) is associated with dysplasia and a high frequency of flt3 gene mutations.
Oyarzo MP; Lin P; Glassman A; Bueso-Ramos CE; Luthra R; Medeiros LJ
Am J Clin Pathol; 2004 Sep; 122(3):348-58. PubMed ID: 15362364
[TBL] [Abstract][Full Text] [Related]
30. No correlation between trisomy 13 and FLT3 duplication in acute myeloid leukemia.
Powell H; Curtis A; Bown N; Taylor P
Cancer Genet Cytogenet; 2005 Jan; 156(1):92-3. PubMed ID: 15588866
[No Abstract] [Full Text] [Related]
31. FLT3/ITD mutation was not detected in a large series of non-Hodgkin lymphomas.
Shiozawa E; Takimoto M; Adachi D; Ota H
Leuk Res; 2004 Sep; 28(9):997-8. PubMed ID: 15234579
[No Abstract] [Full Text] [Related]
32. Tyrosine kinases as targets for cancer therapy.
Krause DS; Van Etten RA
N Engl J Med; 2005 Jul; 353(2):172-87. PubMed ID: 16014887
[No Abstract] [Full Text] [Related]
33. Novel FLT3 tyrosine kinase inhibitors.
Levis M; Small D
Expert Opin Investig Drugs; 2003 Dec; 12(12):1951-62. PubMed ID: 14640939
[TBL] [Abstract][Full Text] [Related]
34. Cooperative group tissue banks as research resources: the cancer and leukemia group B tissue repositories.
Schilsky RL; Dressler LM; Bucci D; Monovich L; Jewell S; Suster S; Caligiuri MA; Kantoff PW; Compton C
Clin Cancer Res; 2002 May; 8(5):943-8. PubMed ID: 12006505
[No Abstract] [Full Text] [Related]
35. Development of a quantitative-PCR method for specific FLT3/ITD monitoring in acute myeloid leukemia.
Beretta C; Gaipa G; Rossi V; Bernasconi S; Spinelli O; Dell'Oro MG; Rizzari C; Rambaldi A; Biondi A; Cazzaniga G
Leukemia; 2004 Aug; 18(8):1441-4. PubMed ID: 15201851
[No Abstract] [Full Text] [Related]
36. Targeting receptor tyrosine kinase signaling in acute myeloid leukemia.
Doepfner KT; Boller D; Arcaro A
Crit Rev Oncol Hematol; 2007 Sep; 63(3):215-30. PubMed ID: 17658267
[TBL] [Abstract][Full Text] [Related]
37. A further case of acute myeloid leukaemia with inv(8)(p11q13) and MOZ-TIF2 fusion.
Billio A; Steer EJ; Pianezze G; Svaldi M; Casin M; Amato B; Coser P; Cross NC
Haematologica; 2002 May; 87(5):ECR15. PubMed ID: 12010678
[No Abstract] [Full Text] [Related]
38. FLT3-activating mutations in acute promyelocytic leukaemia: a rationale for risk-adapted therapy with FLT3 inhibitors.
Gilliland DG
Best Pract Res Clin Haematol; 2003 Sep; 16(3):409-17. PubMed ID: 12935959
[TBL] [Abstract][Full Text] [Related]
39. Point mutations in the FLT3 gene in AML.
Griffin JD
Blood; 2001 Apr; 97(8):2193A-2193. PubMed ID: 11290575
[No Abstract] [Full Text] [Related]
40. A new and recurrent activating length mutation in exon 20 of the FLT3 gene in acute myeloid leukemia.
Spiekermann K; Bagrintseva K; Schoch C; Haferlach T; Hiddemann W; Schnittger S
Blood; 2002 Nov; 100(9):3423-5. PubMed ID: 12384447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
